Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded

from Neutral to Buy. The price target for CVS Health has been raised from $95 to $113. CVS Health's shares closed at $98.37 yesterday. Analysts at Leerink Swann upgraded

from Market Perform to Outperform. The price target for Medicines Company has been raised from $24 to $31. Medicines Company's shares closed at $24.70 yesterday. JP Morgan upgraded

from Neutral to Overweight. The price target for JM Smucker has been raised from $107 to $117. JM Smucker's shares closed at $104.19 yesterday. Analysts at Morgan Stanley upgraded

from Equal-weight to Overweight. Lowe's shares closed at $66.52 yesterday.